SCHEMBL8769328

SCHEMBL8769328

[2H][CH]O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36 0.71
Hydroxyl Radical SCHEMBL4416166 0.61
Fluoride SCHEMBL972649 0.61
SCHEMBL23851326 0.61
Ethylene SCHEMBL5821458 0.55
Ethylene SCHEMBL5668825 0.55
Formaldehyde SCHEMBL2160216 0.50
SCHEMBL17616039 0.50
SCHEMBL7042986 0.50
SCHEMBL10738879 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116134035-A 3- (1H-imidazol-2-yl) -2,3,8 a-tetrahydroindol-5 (1H) -one derivatives useful as factor XIA inhibitors 詹森药业有限公司 2023-05-16 CN disclosed
WO-2022262838-A1 DEUTERATED COMPOUNDS USEFUL AS KRAS G12D INHIBITORS SILEXON AI TECHNOLOGY CO., LTD. (CN) 2022-12-22 WO disclosed
EP-3768661-A1 DEUTERATED COMPOUNDS AS ROCK INHIBITORS Fochon Pharmaceuticals, Ltd. (CN) 2021-01-27 EP disclosed
WO-2019179525-A1 DEUTERATED COMPOUNDS AS ROCK INHIBITORS FOCHON PHARMACEUTICALS, LTD. (CN) 2019-09-26 WO disclosed
EP-0792146-A1 INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES HEMASURE, INC. (US) 1997-09-03 EP disclosed
WO-1997002028-A1 INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES HEMASURE, INC. (US) 1997-01-23 WO disclosed